Epoch Investment Partners, Inc.
Position in HALO — Halozyme Therapeutics, Inc.
CIK 1305841
New York, NY
Position in HALO
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$73,573,304
+$37,678,244 QoQ
Shares Held
1,138,377
+113.4% QoQ
Ownership
0.960%
of shares outstanding
% of Portfolio
0.46%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2022
14 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 100.ToString("F0")%
None 0.ToString("F0")%
Common Shares in HALO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Epoch Investment Partners, Inc. holds $258,238,358 across 3 Biotechnology names. HALO ranks #2 (28.5% of the industry book) .
All Filings in HALO
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $73,573,304 | 1,138,377 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $35,895,060 | 533,359 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $43,755,084 | 596,606 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $32,870,449 | 631,881 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $52,786,631 | 827,247 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $37,211,048 | 778,311 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $48,841,003 | 853,267 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $75,191,159 | 1,436,042 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $58,319,336 | 1,433,612 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $42,985,699 | 1,163,033 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $12,676,058 | 331,834 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $11,972,859 | 331,934 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $12,676,559 | 331,934 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $10,717,342 | 188,354 | Shares | Defined | 2023-02-13 | |
| No filing history on record for this holder in this stock. | ||||||